Jilin Aodong Pharmaceutical Group Co., Ltd. (SHE: 000623)
China
· Delayed Price · Currency is CNY 18.50
-0.01 (-0.05%)
Nov 8, 2024, 3:04 PM CST
Jilin Aodong Pharmaceutical Group Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 1,430 | 1,460 | 1,781 | 1,781 | 1,709 | 1,404 | Upgrade
|
| Depreciation & Amortization | 232.74 | 232.74 | 225.63 | 204.16 | 195.46 | 194.02 | Upgrade
|
| Other Amortization | 6.94 | 6.94 | 4.85 | 4.03 | 3.89 | 2.08 | Upgrade
|
| Loss (Gain) From Sale of Assets | -36.16 | -36.16 | -3.16 | 0.94 | 0.64 | 0.19 | Upgrade
|
| Asset Writedown & Restructuring Costs | 3.25 | 3.25 | 1.67 | 2.84 | 25.53 | 57.63 | Upgrade
|
| Loss (Gain) From Sale of Investments | -1,238 | -1,238 | -1,005 | -1,748 | -1,762 | -1,285 | Upgrade
|
| Provision & Write-off of Bad Debts | 21.38 | 21.38 | 11.62 | 5.15 | -0.57 | -3.76 | Upgrade
|
| Other Operating Activities | 426.9 | 158.66 | 188.3 | 143.12 | 127.91 | 119.37 | Upgrade
|
| Change in Accounts Receivable | -304.33 | -304.33 | -189.01 | 6.42 | 58.67 | 40.5 | Upgrade
|
| Change in Inventory | -16.93 | -16.93 | -301.23 | -59.61 | -20.54 | -7.62 | Upgrade
|
| Change in Accounts Payable | -97.31 | -97.31 | 443.58 | 31.83 | 64.19 | -142.63 | Upgrade
|
| Change in Other Net Operating Assets | -118.56 | -118.56 | -610.91 | - | - | - | Upgrade
|
| Operating Cash Flow | 306.14 | 68.06 | 423.86 | 324.85 | 390.41 | 379.46 | Upgrade
|
| Operating Cash Flow Growth | 226.15% | -83.94% | 30.48% | -16.79% | 2.89% | 9.15% | Upgrade
|
| Capital Expenditures | -380.39 | -419.52 | -270.97 | -313.3 | -227.38 | -222.4 | Upgrade
|
| Sale of Property, Plant & Equipment | 1.06 | 34.61 | 3.08 | 36.94 | 1.42 | 1.3 | Upgrade
|
| Cash Acquisitions | - | - | -2.13 | - | -0.95 | - | Upgrade
|
| Investment in Securities | 581.47 | 524.4 | -1,112 | -1,081 | -96.57 | 106.56 | Upgrade
|
| Other Investing Activities | -214.64 | 624.13 | 828.75 | 646.6 | 508.69 | 272.42 | Upgrade
|
| Investing Cash Flow | -12.5 | 763.62 | -553.21 | -710.4 | 185.21 | 157.89 | Upgrade
|
| Short-Term Debt Issued | - | 653.05 | 641.98 | 302.36 | 306.86 | 13.09 | Upgrade
|
| Total Debt Issued | 3,361 | 653.05 | 641.98 | 302.36 | 306.86 | 13.09 | Upgrade
|
| Short-Term Debt Repaid | - | -651.69 | -374.93 | -342.38 | -21.56 | -30.56 | Upgrade
|
| Total Debt Repaid | -3,325 | -651.69 | -374.93 | -342.38 | -21.56 | -30.56 | Upgrade
|
| Net Debt Issued (Repaid) | 36.81 | 1.36 | 267.05 | -40.02 | 285.3 | -17.47 | Upgrade
|
| Repurchase of Common Stock | -150 | -150 | -170.04 | -100 | -300.03 | - | Upgrade
|
| Common Dividends Paid | -819.75 | -400.57 | -377.76 | -255.71 | -252.3 | -240.83 | Upgrade
|
| Other Financing Activities | 48.18 | - | 109.68 | 33.32 | -16.47 | -1.47 | Upgrade
|
| Financing Cash Flow | -884.76 | -549.21 | -171.07 | -362.4 | -283.51 | -259.77 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.31 | -0.72 | -4.12 | 1.73 | 4.02 | -1.86 | Upgrade
|
| Net Cash Flow | -590.81 | 281.75 | -304.55 | -746.23 | 296.13 | 275.72 | Upgrade
|
| Free Cash Flow | -74.24 | -351.46 | 152.89 | 11.54 | 163.02 | 157.06 | Upgrade
|
| Free Cash Flow Growth | - | - | 1224.31% | -92.92% | 3.80% | 53.48% | Upgrade
|
| Free Cash Flow Margin | -2.47% | -10.19% | 5.33% | 0.50% | 7.24% | 5.09% | Upgrade
|
| Free Cash Flow Per Share | -0.06 | -0.27 | 0.12 | 0.01 | 0.13 | 0.12 | Upgrade
|
| Cash Income Tax Paid | 248.27 | 304.37 | 205.93 | 207.45 | 286.46 | 495.46 | Upgrade
|
| Levered Free Cash Flow | -149.84 | -526.04 | -2.86 | -139.08 | 12.79 | -48.33 | Upgrade
|
| Unlevered Free Cash Flow | -78.99 | -435.83 | 86.51 | -57.53 | 92.05 | 22.35 | Upgrade
|
| Change in Net Working Capital | -122.31 | 340.06 | -45.81 | -43.92 | -161.17 | 59.89 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.